RFL
Rafael Holdings, Inc.
NYSE · Real Estate · Real Estate - Services · US
$1.30
+0.78%Price chart
Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16Oct 21
Key dataOct 21, 2026
Open$1.31
From 52W high−65.61%
Volume45003.00
Market cap$67.60M
P/E (TTM)—
P/S (TTM)69.0x
Div yield—
Key dataOct 21, 2026
Open
$1.31
From 52W high
−65.61%
Volume
45003.00
Market cap
$67.60M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.4x
P/E (TTM)
—
RSI (14)
30.6
MomentumView details →
1D Return
+0.78%
YTD Return
+8.47%
SummaryUpdated Apr 1, 2026
Rafael Holdings, Inc. (NASDAQ:RFL) is a dual-purpose investment company founded in 2017 and publicly traded since March 2018. The company operates as a holding entity with interests in two distinct sectors: pharmaceutical development through its subsidiary Rafael Pharmaceuticals, and commercial real estate assets. Headquartered in Newark, New Jersey, Rafael Holdings represents an unusual corporate structure that combines biotech investment with real estate operations, creating a diversified investment vehicle for shareholders seeking exposure to both high-risk pharmaceutical development and stable real estate income.
Similar companies
Latest newsMore news →
Rafael Holdings, Inc. reported preliminary Q3 2026 results, disclosing clinical trial data including an overall survival hazard ratio of 0.154 in the INPDR group and 0.057 in the expanded group.22d agoRafael Holdings announced topline results from the pivotal Phase 3 TransportNPC study of Trappsol Cyclo in Niemann-Pick Disease Type C, reporting that the drug missed statistical significance on the primary endpoint but showed a directionally favorable treatment effect.22d agoRafael Chairman Yuval Steinitz announces plans to expand the company's presence in the U.S., Germany, and India, including production and R&D facilities.93d ago